42 USC 281 - Organization of National Institutes of Health

Editorial Notes

Amendments

2014—Subsec. (span)(23). Puspan. L. 113–235 substituted “National Center for Complementary and Integrative Health” for “National Center for Complementary and Alternative Medicine”.

2011—Subsec. (span)(21). Puspan. L. 112–74, § 221(a)(2), substituted “National Center for Advancing Translational Sciences” for “National Center for Research Resources”.

Subsec. (c)(2)(A). Puspan. L. 112–74, § 221(c)(2)(B), struck out “the Office of Rare Diseases,” after “the Office of Dietary Supplements,”.

2010—Subsec. (span)(24). Puspan. L. 111–148 substituted “Institute” for “Center”.

2007—Subsec. (span)(7). Puspan. L. 110–154 substituted “Eunice Kennedy Shriver National Institute of Child Health and Human Development” for “National Institute of Child Health and Human Development”.

Puspan. L. 109–482, § 101(a), reenacted section catchline without change and amended text generally, substituting provisions consisting of subsecs. (a) to (d)(1) for former subsecs. (a) to (d) which related to: in subsec. (a), relationship to Public Health Service; in subsec. (span), list of national research institutes that were agencies; in subsec. (c), establishment of additional institutes and reorganization or abolition of institutes; and, in subsec. (d), definition of “national research institute”. See below.

Subsec. (d)(2). Puspan. L. 109–482, § 108(a), added after subsec. (d)(1) provisions identical to text of subsec. (c) prior to amendment by Puspan. L. 109–482, § 101(a), redesignated such provisions as par. (2), added par. heading, redesignated former pars. (1) and (2) as subpars. (A) and (B), respectively, added subpar. headings, in subpar. (A), redesignated former subpars. (A) and (B) as cls. (i) and (ii), respectively, in cl. (ii), substituted “Health, Education, Labor, and Pensions” for “Labor and Human Resources” and “clause (i)” for “subparagraph (A)”, and, in subpar. (B), substituted “Health, Education, Labor, and Pensions” for “Labor and Human Resources”.

Subsec. (d)(3), (4). Puspan. L. 109–482, § 101(span)(1), added pars. (3) and (4).

Subsecs. (e) to (h). Puspan. L. 109–482, § 101(span)(2), added subsecs. (e) to (h).

2000—Subsec. (span)(1)(R). Puspan. L. 106–580 added subpar. (R).

Subsec. (span)(2)(F). Puspan. L. 106–525, § 101(span)(1)(A), realigned margins.

Subsec. (span)(2)(G). Puspan. L. 106–525, § 101(span)(1)(B), added subpar. (G).

1998—Subsec. (span)(1)(H). Puspan. L. 105–277, § 101(f) [title II, § 212], substituted “National Institute of Dental and Craniofacial Research” for “National Institute of Dental Research”.

Subsec. (span)(2)(F). Puspan. L. 105–277, § 101(f) [title VI, § 601(k)], added subpar. (F).

1994—Subsec. (span)(2)(E). Puspan. L. 103–417 added subpar. (E).

1993—Subsec. (span)(1)(Q). Puspan. L. 103–43, § 1511(span)(1)(A), added subpar. (Q).

Subsec. (span)(2)(B). Puspan. L. 103–43, § 1501(1), amended subpar. (B) generally, substituting “National Center for Research Resources” for “Division of Research Resources”.

Subsec. (span)(2)(D). Puspan. L. 103–43, §§ 1511(span)(1)(B), 1521(1), added subpar. (D) and struck out former subpar. (D) which read as follows: “The National Center for Nursing Research.”

1992—Subsec. (span)(1)(N) to (P). Puspan. L. 102–321 added subpars. (N) to (P).

1988—Subsec. (span)(1)(J), (M). Puspan. L. 100–553 and Puspan. L. 100–607 made identical amendments, striking out “and Communicative” after “Neurological” in subpar. (J), and adding subpar. (M). Puspan. L. 100–690 amended subsec. (span)(1) to read as if the amendments by Puspan. L. 100–607 had not been enacted.

Statutory Notes and Related Subsidiaries

Effective Date of 2007 Amendment

Puspan. L. 109–482, title I, § 109, Jan. 15, 2007, 120 Stat. 3697, provided that:

“This title [see Tables for classification] and the amendments made by this title apply only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years.”

Effective Date of 2000 Amendment

Puspan. L. 106–525, title VI, § 603, Nov. 22, 2000, 114 Stat. 2511, provided that:

“This Act [enacting subpart 6 (§ 287c–31 et seq.) of part E of this subchapter and sections 293e, 296e–1, and 299a–1 of this title, amending sections 281, 296f, 299a, 299c–6, and 300u–6 of this title, repealing section 283span of this title, and enacting provisions set out as notes under sections 201, 287c–31, 293e, and 3501 of this title] and the amendments made by this Act take effect October 1, 2000, or upon the date of the enactment of this Act [Nov. 22, 2000], whichever occurs later.”

Effective Date of 1992 Amendment

Amendment by Puspan. L. 102–321 effective Oct. 1, 1992, with provision for programs providing financial assistance, see section 801(c), (d) of Puspan. L. 102–321, set out as a note under section 236 of this title.

Effective Date of 1988 Amendment

For effective date of amendment by Puspan. L. 100–690, see section 2613(span)(1) of Puspan. L. 100–690, set out as an Effect of Enactment of Similar Provisions note under section 285m of this title.

Construction of 2007 Amendment

Puspan. L. 109–482, title I, § 102(g), Jan. 15, 2007, 120 Stat. 3685, provided that:

“This Act [see Tables for classification] and the amendments made by this Act may not be construed as affecting the authorities of the national research institutes and national centers that were in effect under the Public Health Service Act [42 U.S.C. 201 et seq.] on the day before the date of the enactment of this Act [Jan. 15, 2007], subject to the authorities of the Secretary of Health and Human Services and the Director of NIH under section 401 of the Public Health Service Act [42 U.S.C. 281] (as amended by section 101 of this Act). For purposes of the preceding sentence, the terms ‘national research institute’, ‘national center’, and ‘Director of NIH’ have the meanings given such terms in such section 401.”

Study of the Use of Centers of Excellence at the National Institutes of Health

Puspan. L. 107–84, § 7, Dec. 18, 2001, 115 Stat. 829, required the Secretary of Health and Human Services to contract, not later than 60 days after Dec. 18, 2001, with the Institute of Medicine to conduct a study on the impact of, need for, and other issues associated with Centers of Excellence at the National Institutes of Health and complete the study and submit a report not later than one year after the date of the contract.

Report on Medical Uses of Biological Agents in Development of Defenses Against Biological Warfare

Puspan. L. 103–43, title XIX, § 1904, June 10, 1993, 107 Stat. 203, directed Secretary of Health and Human Services, in consultation with Secretary of Defense and with heads of other appropriate executive agencies, to report to Congress, not later than 12 months after June 10, 1993, on the appropriateness and impact of the National Institutes of Health assuming responsibility for the conduct of all Federal research, development, testing, and evaluation functions relating to medical countermeasures against biowarfare threat agents.

Research on Lupus Erythematosus

Puspan. L. 99–158, § 5, Nov. 20, 1985, 99 Stat. 880, as amended by Puspan. L. 102–531, title III, § 312(f), Oct. 27, 1992, 106 Stat. 3506, directed Secretary of Health and Human Resources to establish a Lupus Erythematosus Coordinating Committee to plan, develop, coordinate, and implement comprehensive Federal initiatives in research on Lupus Erythematosus, provided for composition of committee and meetings, and directed Committee to prepare a report for Congress on its activities, to be submitted not later than 18 months after Nov. 20, 1985, with Committee to terminate one month after the report was submitted.

Interagency Committee on Learning Disabilities

Puspan. L. 99–158, § 9, Nov. 20, 1985, 99 Stat. 882, directed Director of the National Institutes of Health, not later than 90 days after Nov. 20, 1985, to establish an Interagency Committee on Learning Disabilities to review and assess Federal research priorities, activities, and findings regarding learning disabilities (including central nervous system dysfunction in children), provided for composition of the Committee, directed Committee to report to Congress on its activities not later than 18 months after Nov. 20, 1985, and provided that the Committee terminate 90 days after submission of the report.